Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck

BACKGROUND: Cetuximab, a monoclonal antibody targeting the Epidermal Growth Factor Receptor (EGFR), has demonstrated activity in various tumor types. Using dynamic contrast-enhanced computed tomography (DCE-CT), we investigated the early activity of cetuximab monotherapy in previously untreated pati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Radiol Oncol
Autores principales: Schmitz, Sandra, Rommel, Denis, Michoux, Nicolas, Lhommel, Renaud, Hanin, François-Xavier, Duprez, Thierry, Machiels, Jean-Pascal
Formato: Artigo
Lenguaje:Inglês
Publicado: Versita, Warsaw 2015
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362602/
https://ncbi.nlm.nih.gov/pubmed/25810697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2014-0030
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares